Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,856 | 34 | 40.2% |
| Food and Beverage | $27,067 | 1,581 | 29.5% |
| Consulting Fee | $15,705 | 5 | 17.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,190 | 5 | 8.9% |
| Travel and Lodging | $3,584 | 17 | 3.9% |
| Education | $232.20 | 11 | 0.3% |
| Grant | $41.50 | 1 | 0.0% |
| Gift | $11.15 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $41,488 | 103 | $0 (2024) |
| Eisai Inc. | $18,242 | 65 | $0 (2024) |
| Genentech USA, Inc. | $5,340 | 42 | $0 (2024) |
| Biogen, Inc. | $3,817 | 84 | $0 (2024) |
| ABBVIE INC. | $2,233 | 134 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $1,741 | 91 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,476 | 113 | $0 (2024) |
| UCB, Inc. | $1,062 | 58 | $0 (2024) |
| GENZYME CORPORATION | $867.16 | 43 | $0 (2023) |
| EMD Serono, Inc. | $856.41 | 72 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,960 | 204 | Eisai Inc. ($17,564) |
| 2023 | $3,588 | 207 | AbbVie Inc. ($569.07) |
| 2022 | $3,255 | 205 | Biohaven Pharmaceutical Holding Company Ltd. ($401.87) |
| 2021 | $8,648 | 208 | Lilly USA, LLC ($3,103) |
| 2020 | $8,276 | 169 | Lilly USA, LLC ($5,661) |
| 2019 | $27,006 | 234 | Lilly USA, LLC ($18,536) |
| 2018 | $3,641 | 192 | Lilly USA, LLC ($689.02) |
| 2017 | $3,313 | 237 | Avanir Pharmaceuticals, Inc. ($401.09) |
All Payment Transactions
1,656 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: Narcoplepsy | ||||||
| 12/17/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 12/12/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PAIN | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Neurology | ||||||
| 12/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.01 | General |
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $122.46 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $57.48 | General |
| Category: AMANTADINE | ||||||
| 12/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $37.39 | General |
| Category: AMANTADINE | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Travel and Lodging | Cash or cash equivalent | $8.33 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,462.50 | General |
| Category: Neurology | ||||||
| 11/09/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $585.00 | General |
| Category: Neurology | ||||||
| 11/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.92 | General |
| Category: Neurology | ||||||
| 11/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 499 | 662 | $195,990 | $53,414 |
| 2022 | 7 | 517 | 685 | $199,621 | $59,087 |
| 2021 | 5 | 455 | 545 | $159,220 | $49,888 |
| 2020 | 5 | 361 | 437 | $126,435 | $33,665 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 302 | $85,180 | $17,662 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 166 | $50,265 | $14,697 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $37,435 | $12,950 | 34.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $12,880 | $5,543 | 43.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 19 | 23 | $5,175 | $1,699 | 32.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 24 | $5,055 | $862.45 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 239 | $68,115 | $20,731 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 136 | 136 | $44,200 | $16,583 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 233 | $65,240 | $14,583 | 22.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 24 | 34 | $7,650 | $2,810 | 36.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 13 | 14 | $8,036 | $2,064 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $4,130 | $1,514 | 36.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 12 | 15 | $2,250 | $801.81 | 35.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 152 | 152 | $49,400 | $18,921 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 142 | 199 | $56,715 | $17,106 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 149 | $41,720 | $8,988 | 21.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 18 | $5,310 | $2,644 | 49.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 19 | 27 | $6,075 | $2,229 | 36.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 120 | 168 | $47,880 | $12,087 | 25.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 92 | 92 | $29,900 | $11,411 | 38.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 121 | 144 | $40,320 | $7,256 | 18.0% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 16 | 20 | $4,500 | $1,550 | 34.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 13 | $3,835 | $1,360 | 35.5% |
About Dr. Eric Awad, MD
Dr. Eric Awad, MD is a Neurology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578557500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Awad, MD has received a total of $91,687 in payments from pharmaceutical and medical device companies, with $33,960 received in 2024. These payments were reported across 1,656 transactions from 88 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,856).
As a Medicare-enrolled provider, Awad has provided services to 1,832 Medicare beneficiaries, totaling 2,329 services with total Medicare billing of $196,053. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Atlanta, GA
- Active Since 09/06/2005
- Last Updated 10/06/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578557500
Products in Payments
- Leqembi (Drug) $17,602
- KISUNLA (Drug) $12,805
- EMGALITY (Drug) $9,164
- OCREVUS (Biological) $5,008
- OXTELLAR XR (Drug) $1,311
- NURTEC ODT (Drug) $1,144
- TYSABRI (Biological) $1,010
- KESIMPTA (Drug) $905.51
- QULIPTA (Drug) $783.76
- Briviact (Drug) $651.98
- Fycompa (Drug) $640.09
- DUOPA (Drug) $622.36
- Aimovig (Biological) $596.27
- Gocovri (Drug) $570.14
- ONZETRA Xsail (Drug) $543.94
- GOCOVRI (Drug) $508.23
- AUBAGIO (Drug) $465.74
- BOTOX (Biological) $440.28
- RYTARY (Drug) $431.77
- TROKENDI XR (Drug) $430.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Atlanta
Dr. Joash Lazarus, M.d, M.D
Neurology — Payments: $1.0M
Robert Gilbert, M.d, M.D
Neurology — Payments: $946,678
Douglas Stuart, M.d, M.D
Neurology — Payments: $807,499
Frank Berenson, Md, MD
Neurology — Payments: $628,973
Julio Flamini, M.d, M.D
Neurology — Payments: $554,096
Lawrence Seiden, M.d, M.D
Neurology — Payments: $318,322